MODERNA INC. DL-_0001
Commented by Stefan Feulner on November 25th, 2020 | 11:15 CET
Moderna, Triumph Gold, BioNTech - bet on winners!
Gold has not made it out - for the time being. Due to the decision of the Americans pro Joe Biden and the very successful developments regarding a vaccine against the coronavirus, the precious yellow metal went downhill for the time being. The correction may well continue a little further. However, in the past, these setbacks were lucrative with anti-cyclical entry opportunities. Therefore, one should use the time now to take a closer look at promising gold mines.
Read
Commented by Stefan Feulner on November 20th, 2020 | 11:20 CET
BioNTech, Saturn Oil & Gas, Moderna - these stocks will explode!
Now it's all happening at once with the news in the race against the Corona pandemic. According to BioNTech and its US competitor Moderna, first deliveries of the vaccine are scheduled for the end of this year and the start of 2021. The first step towards normality, even though the head of BioNTech, Ugur Sahin, does not expect a normal social life until the end of 2021 at the earliest. Then, if everything goes smoothly, badly shaken industries should experience an unprecedented renaissance, and their share prices should take off.
Read
Commented by Stefan Feulner on November 17th, 2020 | 09:58 CET
BYD, Upco International, Moderna: bet on the winners!
Who will win the race for the fastest and best vaccine against the Coronavirus? After the first test results, specific trends are emerging. It is clear now, driven by news, large fluctuations and thus high price gains are possible. The overall stock market seems not to care about this, just that a vaccine will be available soon, is enough. After a short correction, the trend goes south again. The market could see significantly higher prices next year.
Read
Commented by Nico Popp on September 4th, 2020 | 09:48 CEST
Moderna, Evotec or Valeo Pharma: Who has the game changer?
The pandemic is driving the markets. But sometimes investors either come too late or bet on the wrong horse. In the analysis, three stocks for which investors hope for the game changer. The fact that the search for a cure for Covid-19 is making high waves on the stock market is shown by stocks like Moderna. Despite the current price correction, the biotech company from the USA achieves an annual performance of a massive 280%. The reason for this soaring performance is easy to find: Moderna is researching a Corona vaccine and has already reported promising interim results. Among other things, the EU has already secured several million vaccine doses in the event of a successful clinical approval procedure.
Read
Commented by Mario Hose on June 2nd, 2020 | 05:58 CEST
Memphasys, Moderna, Paion - Investments in solutions with potential
Biotech companies around the world employ scientists and physicians to study the causes of diseases. The research and development of medical products and solutions usually involves a large number of tests and takes a correspondingly long time. The longer and more extensive this process is, the more capital these companies require from investors. In the race to bring to market preparations or products that improve people's well-being or fulfill desires, the providers of solutions usually have great sales potential and investors may be bought out through a takeover.
Read